For the year ending 2025-12-31, SLDB has $232,540K in assets. $52,530K in debts. $59,900K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 59,900 | |||
| Available-for-sale securities | 127,950 | |||
| Prepaid expenses and other current assets | 16,384 | |||
| Restricted cash, current | 1,222 | |||
| Total current assets | 205,456 | |||
| Operating lease, right-of-use assets | 21,924 | |||
| Property and equipment, gross | 18,359 | |||
| Less accumulated depreciation and amortization | 14,190 | |||
| Property and equipment, net | 4,169 | |||
| Other non-current assets | 223 | |||
| Restricted cash, net of current portion | 768 | |||
| Total non-current assets | 27,084 | |||
| Total assets | 232,540 | |||
| Accounts payable | 3,224 | |||
| Accrued expenses and other current liabilities | 18,945 | |||
| Operating lease liabilities, current | 2,103 | |||
| Finance lease liabilities | 0 | |||
| Derivative liabilities | 9,200 | |||
| Total current liabilities | 33,472 | |||
| Operating lease liabilities, net of current portion | 19,058 | |||
| Total non-current liabilities | 19,058 | |||
| Total liabilities | 52,530 | |||
| Common stock, 0.001 par value 240,000,000 and 120,000,000 shares authorized at december 31, 2025 and 2024, respectively 78,967,888 and 40,468,141 shares issued and outstanding at december 31, 2025 and 2024, respectively | 79 | |||
| Additional paid-in capital | 1,137,654 | |||
| Accumulated other comprehensive income | 52 | |||
| Accumulated deficit | -957,775 | |||
| Total stockholders' equity | 180,010 | |||
| Total liabilities and stockholders' equity | 232,540 | |||
Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc. (SLDB)